Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 4
1966 11
1967 7
1968 10
1969 9
1970 20
1971 17
1972 9
1973 15
1974 20
1975 22
1976 20
1977 16
1978 16
1979 25
1980 21
1981 21
1982 21
1983 20
1984 16
1985 23
1986 4
1987 20
1988 23
1989 11
1990 15
1991 14
1992 16
1993 11
1994 12
1995 9
1996 20
1997 10
1998 9
1999 20
2000 11
2001 15
2002 10
2003 3
2004 14
2005 11
2006 11
2007 19
2008 13
2009 12
2010 15
2011 15
2012 14
2013 12
2014 14
2015 15
2016 15
2017 11
2018 17
2019 3
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

758 results
Results by year
Filters applied: . Clear all
Page 1
Autoimmune Hemolytic Anemia.
Liebman HA and Weitz IC. Med Clin North Am 2017 - Review. PMID 28189175
Autoimmune hemolytic anemia is an acquired autoimmune disorder resulting in the production of antibodies directed against red blood cell antigens causing shortened erythrocyte survival. The disorders can present as a primary disorder (idiopathic) or secondary to other autoimmune disorders, malignancies, or infections. ...
Autoimmune hemolytic anemia is an acquired autoimmune disorder resulting in the production of antibodies directe
Warm antibody autoimmune hemolytic anemia.
Kalfa TA. Hematology Am Soc Hematol Educ Program 2016 - Review. PMID 27913548 Free PMC article.
Autoimmune hemolytic anemia (AIHA) is a rare and heterogeneous disease that affects 1 to 3/100 000 patients per year. AIHA caused by warm autoantibodies (w-AIHA), ie, antibodies that react with their antigens on the red blood cell optimally at 37°C, is the most common type, comprising ∼70% to 80% of all adult cases and ∼50% of pediatric cases. ...Finally, the standard treatment options and newer therapeutic approaches for this chronic autoimmune blood disorder will be reviewed....
Autoimmune hemolytic anemia (AIHA) is a rare and heterogeneous disease that affects 1 to 3/100 000 patients per year. A
Autoimmune hemolytic anemia.
Čermák J and Písačka M. Vnitr Lek 2018. PMID 30193520
Autoimmune hemolytic anemia (AIHA) is caused by auto-antibodies directed against self red blood cell (RBC) surface antigens. ...Key words: anemia hemolytic - autoimmunity - corticosteroids - diagnosis - pathogenesis - rituximab - splenectomy - treatment....
Autoimmune hemolytic anemia (AIHA) is caused by auto-antibodies directed against self red blood cell (RBC) surface anti
Cold agglutinin-mediated autoimmune hemolytic anemia.
Berentsen S, et al. Hematol Oncol Clin North Am 2015 - Review. PMID 26043385
Cold antibody types account for about 25% of autoimmune hemolytic anemias. Primary chronic cold agglutinin disease (CAD) is characterized by a clonal lymphoproliferative disorder. ...
Cold antibody types account for about 25% of autoimmune hemolytic anemias. Primary chronic cold agglutinin disease (CAD) is ch …
Autoimmune Hemolytic Anemia in Children: Mayo Clinic Experience.
Sankaran J, et al. J Pediatr Hematol Oncol 2016. PMID 26925716
We studied 35 pediatric patients with autoimmune hemolytic anemia seen at Mayo Clinic from 1994 to 2014. The median age was 10.0 years and 65.7% were males. ...Autoimmune hemolytic anemia is a rare disorder in pediatric population and most respond well to steroids regardless of the type of antibody. ...
We studied 35 pediatric patients with autoimmune hemolytic anemia seen at Mayo Clinic from 1994 to 2014. The median age …
Autoimmune Hemolytic Anemia and Red Blood Cell Autoantibodies.
Quist E and Koepsell S. Arch Pathol Lab Med 2015 - Review. PMID 26516943
Autoimmune hemolytic anemia is a rare disorder caused by autoreactive red blood cell (RBC) antibodies that destroy RBCs. Although autoimmune hemolytic anemia is rare, RBC autoantibodies are encountered frequently and can complicate transfusion workups, impede RBC alloantibody identification, delay distribution of compatible units, have variable clinical significance that ranges from benign to life-threatening, and may signal an underlying disease or disorder. ...
Autoimmune hemolytic anemia is a rare disorder caused by autoreactive red blood cell (RBC) antibodies that destroy RBCs
Murine models of autoimmune hemolytic anemia.
Howie HL and Hudson KE. Curr Opin Hematol 2018 - Review. PMID 30169458 Free PMC article.
PURPOSE OF REVIEW: Pathogenic autoantibodies directed against red blood cells (RBCs) may lead to autoimmune hemolytic anemia (AIHA), a severe and sometimes fatal disease. ...
PURPOSE OF REVIEW: Pathogenic autoantibodies directed against red blood cells (RBCs) may lead to autoimmune hemolytic anemi
Autoimmune hemolytic anemia.
Izui S. Curr Opin Immunol 1994 - Review. PMID 7710716
Autoimmune hemolytic anemia (AHA) is characterized by the production of Coombs' antibodies, which are responsible for the destruction of red blood cells (RBCs). Analysis of both monoclonal anti-RBC autoantibodies derived from autoimmune New Zealand black mice and transgenic mice expressing a pathogenic IgM anti-RBC autoantibody has considerably improved our understanding of the B-cell responses involved in AHA, although our knowledge of T-cell immunity in AHA is still limited. ...
Autoimmune hemolytic anemia (AHA) is characterized by the production of Coombs' antibodies, which are responsible for t
Venous thromboembolism related to warm autoimmune hemolytic anemia: a case-control study.
Lecouffe-Desprets M, et al. Autoimmun Rev 2015 - Review. PMID 26162301
BACKGROUND: The risk of venous thromboembolism (VTE) during warm autoimmune hemolytic anemia (wAIHA) is apparent in several published series. Unlike proximate disorders (autoimmune thrombocytopenia, non-immune hemolytic diseases) little is known about the presentation and risk factors for VTE in this setting. ...
BACKGROUND: The risk of venous thromboembolism (VTE) during warm autoimmune hemolytic anemia (wAIHA) is apparent in sev …
Autoimmune hemolytic anemia.
Schreiber AD. Pediatr Clin North Am 1980. PMID 7383713
In autoimmune hemolytic anemia, individuals produce antibodies directed against one of their own erythrocyte membrane antigens. The hemolysis in autoimmune hemolytic anemia is most commonly extravascular rather than intravascular, and the liver and spleen play a major role in the clearance of the antibody-coated cells. ...
In autoimmune hemolytic anemia, individuals produce antibodies directed against one of their own erythrocyte membrane a …
758 results
Jump to page
Feedback